Cargando…
Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be
A significant proportion of patients with interstitial lung disease (ILD) may develop a progressive fibrosing phenotype characterized by worsening of symptoms and pulmonary function, progressive fibrosis on chest computed tomography and increased mortality. The clinical course in these patients mimi...
Autores principales: | Goos, Tinne, De Sadeleer, Laurens J., Yserbyt, Jonas, Verleden, Geert M., Vermant, Marie, Verleden, Stijn E., Wuyts, Wim A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004662/ https://www.ncbi.nlm.nih.gov/pubmed/33807034 http://dx.doi.org/10.3390/jcm10061330 |
Ejemplares similares
-
Towards the Essence of Progressiveness: Bringing Progressive Fibrosing Interstitial Lung Disease (PF-ILD) to the Next Stage
por: De Sadeleer, Laurens J., et al.
Publicado: (2020) -
Multiplex protein profiling of bronchoalveolar lavage in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis
por: Stijn, Willems, et al.
Publicado: (2013) -
Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023) -
A Hundred Years of Diagnosing Superficial Fungal Infections: Where Do We Come From, Where Are We Now and Where Would We Like To Go?
por: GRÄSER, Yvonne, et al.
Publicado: (2020) -
Where are we now?
Publicado: (1977)